Marwan I. Abdullah

Thornborrow Drive
Stoke-on-trent, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Assessment of Surgical Antimicrobial Prophylaxis Practices in a Tertiary Hospital in Iraq.

Assessment of Surgical Antimicrobial Prophylaxis Practices in a Tertiary Hospital in Iraq.

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: February 27, 2026

Inhibition of branched-chain alpha-keto acid dehydrogenase kinase augments the sensitivity of ovarian and breast cancer cells to paclitaxel.

Inhibition of branched-chain alpha-keto acid dehydrogenase kinase augments the sensitivity of ovarian and breast cancer cells to paclitaxel.

Journal: British journal of cancer

Published: August 25, 2022

Screening a library of approved drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian cancer cell death.

Screening a library of approved drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian cancer cell death.

Journal: Scientific reports

Published: August 01, 2018

The poor design of clinical trials of statins in oncology may explain their failure - Lessons for drug repurposing.

The poor design of clinical trials of statins in oncology may explain their failure - Lessons for drug repurposing.

Journal: Cancer treatment reviews

Published: April 03, 2018

Combined Effect of Anticancer Agents and Cytochrome C Decorated Hybrid Nanoparticles for Liver Cancer Therapy.

Combined Effect of Anticancer Agents and Cytochrome C Decorated Hybrid Nanoparticles for Liver Cancer Therapy.

Journal: Pharmaceutics

Published: March 23, 2018

Inhibition of the mevalonate pathway augments the activity of pitavastatin against ovarian cancer cells.

Inhibition of the mevalonate pathway augments the activity of pitavastatin against ovarian cancer cells.

Journal: Scientific reports

Published: March 14, 2017

Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer.

Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer.

Journal: Scientific reports

Published: March 01, 2017

Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells.

Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells.

Journal: Journal of ovarian research

Published: July 29, 2015

Showing 1-8 of 8

Last Updated: 09/26/2026